Cagrilintide + Semaglutide

This blend pairs cagrilintide (an amylin analogue) with semaglutide (a GLP-1 receptor agonist). The fixed combination has been studied in phase 3 trials under the name CagriSema.

The combination is not an approved medicine. A blend needs a lab report that reports the amount of each peptide separately.

Before you buy

• A lab report for this exact batch (a Certificate of Analysis)
• A batch number on the vial that matches the report
• A sealed vial of freeze-dried powder, stored cold and away from light as the label requires

Informational summary only, not medical advice. Read the safety guide and consult a qualified healthcare professional.